- Home
- ATOS vs QIPT Comparison
ATOS vs QIPT Comparison
Compare ATOS & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- QIPT
- Stock Information
- Founded
- ATOS 2009
- QIPT 1993
- Country
- ATOS United States
- QIPT United States
- Employees
- ATOS N/A
- QIPT N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- QIPT
- Sector
- ATOS Health Care
- QIPT
- Exchange
- ATOS Nasdaq
- QIPT Nasdaq
- Market Cap
- ATOS 96.8M
- QIPT 112.0M
- IPO Year
- ATOS 2012
- QIPT N/A
- Fundamental
- Price
- ATOS $0.65
- QIPT $2.25
- Analyst Decision
- ATOS Strong Buy
- QIPT Strong Buy
- Analyst Count
- ATOS 3
- QIPT 2
- Target Price
- ATOS $7.00
- QIPT $6.50
- AVG Volume (30 Days)
- ATOS 520.3K
- QIPT 124.8K
- Earning Date
- ATOS 03-25-2025
- QIPT 05-14-2025
- Dividend Yield
- ATOS N/A
- QIPT N/A
- EPS Growth
- ATOS N/A
- QIPT N/A
- EPS
- ATOS N/A
- QIPT N/A
- Revenue
- ATOS N/A
- QIPT $244,723,000.00
- Revenue This Year
- ATOS N/A
- QIPT $3.35
- Revenue Next Year
- ATOS N/A
- QIPT $5.39
- P/E Ratio
- ATOS N/A
- QIPT N/A
- Revenue Growth
- ATOS N/A
- QIPT 3.82
- 52 Week Low
- ATOS $0.65
- QIPT $2.23
- 52 Week High
- ATOS $2.31
- QIPT $4.35
- Technical
- Relative Strength Index (RSI)
- ATOS 31.82
- QIPT 36.51
- Support Level
- ATOS $0.66
- QIPT $2.23
- Resistance Level
- ATOS $0.71
- QIPT $2.42
- Average True Range (ATR)
- ATOS 0.04
- QIPT 0.10
- MACD
- ATOS -0.00
- QIPT 0.01
- Stochastic Oscillator
- ATOS 0.00
- QIPT 10.00
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.